 |
|
CME PUBLICATION
Improving Quality of Life in Patients With Atrial Fibrillation Through Safer, More Individualized Treatment Approaches
Read today:
www.Med-IQ.com/a666
CLINICAL DISCUSSION
AF Management Community-of-Practice Audioconference: Tuesday, July 23
at 6 PM ET—Register
BECOME A MED-IQ MEMBER FOR FREE
Sign up today and access
award-winning medical education.
Learn more about your
member benefits.
Have questions?
Contact a Med-IQ Concierge Specialist. Call (toll-free)
866 858 7434 or e-mail
info@med-iq.com.
Med-IQ.
Inspiring Medical Education. |
 |
BALTIMORE, MD—June 11, 2013—A complimentary, multicomponent, educational initiative designed to improve cardiologists’ and electrophysiologists’ ability to recognize risk factors associated with the progression of atrial fibrillation (AF) has been provided by Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME).
Improving Quality of Life in Patients With Atrial Fibrillation Through Safer, More Individualized Treatment Approaches consists of a CME publication based on a roundtable discussion of AF experts and national community-of-practice audioconferences. This series is designed to help specialists individualize treatment for their patients with AF by highlighting the underlying disease pathology as well as the safety and efficacy of available treatment options.
AF is the most frequently diagnosed arrhythmia in clinical practice, affecting more than 6 million people in the United States. Suboptimal management of this condition is associated with increases in hospitalizations, healthcare costs, and even mortality and results in decreased patient quality of life. Contemporary AF management strategies vary widely; this reality is related to a lack of definitive expert consensus on effective treatment strategies, an under-appreciation of the clinical significance of AF, and a lack of emphasis on individual patient factors when designing treatment plans. Deviations from guidelines, emergence of new drugs, multiple recent guideline updates, and suboptimal patient adherence create a significant need for education on current evidence and best practices for managing this complex disease.
“Clinicians who participate in this series will be able to effectively describe the potential contribution of patient factors and adherence on the progression of AF and disease-related outcomes,” said Gerald V. Naccarelli, MD, of Penn State University College of Medicine in Hershey, PA. “They should also successfully be able to identify available pharmacologic treatment options for rate and rhythm control in patients with AF and discuss how their respective safety and efficacy profiles factor into the development of individualized care plans.”
To access the CME publication, visit www.Med-IQ.com/a666. To register for the audioconference on Tuesday, July 23, at 6:00 PM ET, complete this brief online form, call (toll-free) 866 858 7434, or e-mail info@med-iq.com.
CHAIR
 |
|
Gerald V. Naccarelli, MD
Bernard Trabin Chair in Cardiology
Professor of Medicine
Chief, Division of Cardiology
Penn State University College of Medicine
Hershey, PA |
FACULTY
 |
|
Kenneth A. Ellenbogen, MD
Chairman, Division of Cardiology
Pauley Heart Center
Virginia Commonwealth University
Director, Clinical Cardiac Electrophysiology & Pacing
Medical College of Virginia & McGuire Veterans Administration Medical Center
Richmond, VA |
| |
|
|
 |
|
James A. Reiffel, MD
Professor of Clinical Medicine
Columbia University College of Physicians & Surgeons
Co-Director, Electrophysiology Laboratory
Columbia University Medical Center
New York, NY |
| |
|
|
 |
|
Oussama M. Wazni, MD
Co-Director, AF Center
Cardiac Pacing and Electrophysiology
Director, Clinical Atrial Fibrillation Research
Department of Cardiovascular Medicine
Heart and Vascular Institute
Cleveland Clinic
Cleveland, OH |
This publication is approved for AMA PRA Category 1 Credit™.
Sponsored by Med-IQ.
This series is supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact: |
close
